Spinal Muscular Atrophy Type II
9 clinical trials · Condition
◉ Watch Spinal Muscular Atrophy Type II
| Record | Firm | Date |
|---|---|---|
| Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy (NCT06137612) | University Hospital, Basel, Switzerland | 2020-08-17 |
| Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi (NCT04042025) | Novartis Gene Therapies | 2020-02-10 |
| Spinraza in Adult Spinal Muscular Atrophy (NCT03709784) | Washington University School of Medicine | 2018-08-16 |
| Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients. (NCT01302600) | Hoffmann-La Roche | 2010-11-01 |
| Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III (NCT00439569) | Westat | 2008-01-01 |
Track Spinal Muscular Atrophy Type II automatically
Every clearance here is in the API, with alerts when new ones post.